JRCT ID: jRCT2080225221
Registered date:08/06/2020
Basic Information
Recruitment status | recruiting |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 08/07/2020 |
Target sample size | 1646 |
Countries of recruitment | Japan,Asia except Japan,North America,South America,Europe |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : Lasmiditan Therapeutic category code : 119 Other agents affecting central nervous system Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | efficacy |
---|---|
Secondary Outcome | efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 6age old |
---|---|
Age maximum | <= 17age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT04396236,JapicCTI-205317 |